Loading...

Natdac Tablet (Daclatasvir)

In stock
SKU
101260K
Rating:
100 % of 100
$0.00

Buy Natdac 60 mg (Daclatasvir), Natdac (Daclatasvir) is an antiviral medicine that prevents the hepatitis C virus (HCV) from multiplying in your body. Natdac is used to treat genotype 1 and genotype 3 chronic hepatitis C in adults with or without cirrhosis. Natdacis was given together with another drug called Sovaldi (sofosbuvir). Daklinza is another trade name for Daclatasvir.

Read More

Natdac 60mg Tablet (Daclatasvir 60mg)

Package QTY Price Add To Cart
28 Tablet/s (1 Bottle) $140.00
56 Tablet/s (2 Bottles) $260.00
84 Tablet/s (3 Bottles) $380.00

What is Natdac Tablet (Daclatasvir)?

Natdac (Daclatasvir) is an antiviral medicine that prevents the hepatitis C virus (HCV) from multiplying in your body. Natdac is used to treat genotype 1 and genotype 3 chronic hepatitis C in adults with or without cirrhosis. Natdacis was given together with another drug called Sovaldi (sofosbuvir). Natdac tablets contain the active ingredient daclatasvir, which is a type of medicine called an antiviral. It is used in combination with other medicines to treat chronic hepatitis C. Hepatitis C is a virus that infects the liver and leads to liver damage. Once the virus is inside the liver cells it multiplies. Part of this process involves the virus making copies of its genetic material (RNA and DNA). Daclatasvir Tablets are highly effective in treating Hepatitis C, providing a solution for individuals affected by the condition. Daklinza is another brand name for Daclatasvir.

How does Natdac Tablet (Daclatasvir) work?

Daclatasvir works by blocking the action of an enzyme called 5A (NS5A) in the hepatitis C virus, which is essential for the virus to multiply. This stops the hepatitis C virus from multiplying, which lowers the amount of the hepatitis C virus in the liver. This helps to reduce liver damage and improves liver function.

Daclatasvir must be used in combination with other medicines that attack the hepatitis C virus in different ways. If daclatasvir is used on its own there is a high chance that the hepatitis C virus will become resistant to it.

What is Natdac Tablet (Daclatasvir) used for?

Treating chronic hepatitis C infections (genotypes 1, 3, and 4) in adults with uncomplicated liver disease whose liver is still functioning correctly (compensated liver disease). Natdac may be used in people who have not yet received treatment for their hepatitis C, or for people whose disease has not improved with previous treatment. Natdac may be used in combination with sofosbuvir (Sovaldi), either with or without ribavirin (Rebetol), or with ribavirin plus peginterferon alfa (ViraferonPeg or Pegasys).

Natdac Tablet (Daclatasvir) side effects

Get emergency medical help if you have signs of an allergic reaction to Natdac: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Before taking Natdac Tablet (Daclatasvir) medicine

  • You should not use Natdac if you are allergic to daclatasvir. If you take daclatasvir with sofosbuvir, there may be other reasons you should not take this combination treatment. Tell your doctor about all your medical conditions.
  • Some medicines can interact with Natdac/Daklinza and should not be used at the same time. Your doctor may need to change your treatment plan if you use any of the following drugs: rifampin, carbamazepine, and phenytoin.
  • To make sure Natdac is safe for you, tell your doctor if you have:
  • liver problems other than hepatitis C;
  • heart disease;
  • if you also use amiodarone (a heart rhythm medicine); or
  • if you have received a liver transplant.
  • It is not known whether Natdac will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
  • It is not known whether daclatasvir passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breastfeeding a baby.
  • Natdac is not approved for use by anyone younger than 18 years old.

How should I take Natdac Tablet (Daclatasvir/Daklinza)?

  • Natdac is usually taken for 12 weeks. Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.
  • Natdac must be given in combination with sofosbuvir and it should not be used alone.
  • You may take Natdac with or without food.
  • Hepatitis C is often treated with a combination of drugs. Use all medications as directed by your doctor. Read all patient information, medication guides, and instruction sheets provided to you. Ask your doctor or pharmacist if you have any questions.
  • Do not stop using any of your hepatitis C medicines without your doctor's advice. Do not change your doses or medication schedule without first asking your doctor. Every person with chronic hepatitis C should remain under the care of a doctor.
  • You will need frequent blood tests to check your liver function while using Natdac.
  • Store at room temperature away from moisture and heat.

Natdac Tablet (Daclatasvir) dosing information

Usual Adult Dose for Chronic Hepatitis C:

60 mg orally once a day for 12 weeks

Comments:
-Sustained virologic response rates reduced in HCV genotype 3-infected patients with cirrhosis using this drug with sofosbuvir for 12 weeks; optimal duration of therapy has not been established for patients with cirrhosis.
-The manufacturer product information for sofosbuvir should be consulted.

Use: In combination with sofosbuvir, for the treatment of patients with chronic HCV genotype 3 infection

What happens if I miss a dose?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call to your doctor.

What should I avoid while taking Natdac Tablet (Daclatasvir/Daklinza)?

Taking Natdac will not prevent you from passing hepatitis C to other people. Do not have unprotected sex or share razors or toothbrushes. Talk with your doctor about safe ways to prevent HCV transmission during sex. Sharing drugs or medicine needles is never safe, even for a healthy person.

Drug connection with Natdac Tablet (Daclatasvir)

Serious drug interactions can occur when certain medicines are used together with daclatasvir. Tell each of your healthcare providers about all medicines you use now, and any medicine you start or stop using.

Natdac Tablet (Daclatasvir) may be used in combination with Sofosbuvir or other direct-acting antiviral agents to achieve a sustained virologic response (SVR) in patients with chronic Hepatitis C infection. It is important to follow the prescribed treatment regimen and take the medication as directed by your healthcare provider to ensure the best possible outcome. It is crucial to inform your healthcare provider about any other medications, supplements, or herbal products you are taking, as they may interact with Natdac Tablet (Daclatasvir). Drug interactions can affect the efficacy or safety of the treatment, so it is essential to disclose all relevant information to your healthcare provider. Your healthcare provider will assess potential drug interactions and adjust the treatment plan accordingly. They will carefully consider factors such as the dosage, timing, and duration of each medication to minimize the risk of adverse effects or reduced effectiveness.

FAQs

What is the Generic Name for the trade name drug "Daklinza"?

Daclatasvir mepesuccinate is the Generic Name for the trade name drug Natdac.

What is the Manufacturer's Name of Natdac?

Natdac is manufactured by Natco Pharma, India

Is Natdac approved by FDA?

Yes, Natdac is approved by FDA.

What dosage and form of Natdac Tablet (Daclatasvir) is available?

Natdac is available in 30 mg & 60 mg film-coated tablets

What are the indications and usage of Natdac?

Natdac is an anti-body-drug conjugate indicated for: The treatment of The treat adults with hepatitis C. after the failure of autologous stem cell transplant (ASCT) or after the failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates and The treatment of patients with systemic anaplastic large cell lymphoma after failure of at least one prior multi-agent chemotherapy regimen

These indications are based on the response rate. There are no data available demonstrating improvement in patient-reported outcomes or survival with Natdac.

SOURCING:
onlinegenericmedicine.com is able to source Natdac Brentuximab Vedotin (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment. You can conveniently buy Daclatasvir Tablets from our website, onlinegenericmedicine.com.


DELIVERY:
onlinegenericmedicine.com is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patients address only from India.

Is Natdac available in India?

Natdac is a pharmaceutical drug that legally requires a medical prescription to be dispensed.

onlinegenericmedicine.com facilitates the Export of cancer medicines on the named patient supply. onlinegenericmedicine.com is a facilitator providing input

  • On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
  • Medicine Price.
  • Finding Genuine and reliable sources from Europe, the USA, and Australia
  • Ensuring 100% transparency.
  • Natdac can be made available in Europe, the USA, and Australia, onlinegenericmedicine.com can facilitate the supply of Natdac (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)

Please email us for a bulk discount, We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

How order will be confirmed?

  • The order will be confirmed only after the receipt of
  • Valid prescription of Oncologist
  • Import permit if applicable

Where can I Buy Natdac (Daclatasvir Tablets)?

onlinegenericmedicine.com connects buyers with suppliers who can ship Natdac (Daclatasvir Tablets) (Cancer Treatment Medicines) to any country of the world as per the buyer's requirement and Government regulations of the country. Natdac is manufactured by Natco Pharma Ltd.

onlinegenericmedicine.com provides options for choosing exporters and suppliers of Cancer treatment Medicines We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements. We offer affordable Daclatasvir Tablets on our website, ensuring that you can access the medication at a reasonable price.

Natdac Daclatasvir's price online

  • this can be the opportunity to get the best prices of your hep c treatment.
  • Before contacting us please take into account that the medicine has to be prescribed by a doctor, and you must provide the prescription to us and we will verify it with your doctor.
  • We are able to deliver the Natdac to almost every country in the world, directly to your doctor’s office or through a net of allied pharmacies.
  • If you want more information about Natdac, to get more information about HCV visit our Hep C Blog
  • To get your best Natdac quote visit our online pharmacy.
  • Generic components: Daclatasvir
  • Usually prescribed to treat chronic hep c infection
  • Original Brand Manufactured by Bristol-Myers Squibb

Natdac Launch
On 17th December 2105, Natco Pharma got approval for generic Daclatasvir Dihydrochloride (“ Daclatasvir”) tablets, Natdac 30mg & Natdac 60mg, from Drugs Controller General (India). Daclatasvir (Natdac) is the first-in-class NS5A inhibitor used in combination with Sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection. Compared to other treatment options, this combination not only increases the cure rate but is also regarded as a valuable treatment option in some of the difficult-to-treat HCV patient subsets.

U.S. Food and Drug Administration approved Natdac (Daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections on July 24, 2015. Natdac (Daclatasvir) is the first drug that has demonstrated safety and efficacy to treat genotype 3 HCV infections without the need for co-administration of interferon or ribavirin, two FDA-approved drugs also used to treat HCV infection.

Write Your Own Review
You're reviewing:Natdac Tablet (Daclatasvir)
Your Rating
More Information
Manufacturer :
Equivalent Brand : Daklinza
Generic Search : Daclatasvir
Strength : 60 mg